DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Brines M, Dunne AN, van Velzen M. , et al.
ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes.
Mol Med 2015;
20: 658-666
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.